Recurrence of renal cell carcinoma in a renal allograft after partial trans- plant nephrectomy: a case report. Urol Int. 2009;83:239-241.M. R. Hoda, A. Hamza, S. Wagner, F. Greco, and P. Fornara, "Recurrence of renal cell carcinoma in a renal allograft after partial transplant ...
Late recurrence of renal cell carcinoma (RCC), arbitrarily defined as >10 years post nephrectomy, is rare. The longest known clinical disease-free interval of 36 years was reported by Walter and Gellespie in 1960. We report a case of recurrent RCC presenting 45 years after nephrectomy.Helene ...
Renal cell carcinoma (RCC), is the 10th malignancy worldwide and the most frequent type of kidney cancer in adults. Each year in Europe approximately 88 400 patients are diagnosed with RCC; the incidence and mortality of RCC are rising at a rate of 2–3% per decade, therefore novel therapi...
Esrig D, Ahlering TE, Lieskovsky G, Skinner DG. Ex- perience with fossa recurrence of renal cell carcinoma. J Urol 1992;147:1491-1494.Esrig D, Ahlering TE, Lieskovsky G, Skinner DG. Experience with fossa recurrence of renal cell carcinoma. J Urol 1992;147(6):1491 A/4....
The patient has remained well without focal recurrence or distant metastasis for 63 months since the operation. 36 cases of spontaneous rupture of renal cell carcinoma in Japan were collected and are here in discussed.Y. Hara... Y Hara,T Ida - 西日本泌尿器科 被引量: 0发表: 2002年 Abstrac...
(2015) Delayed Recurrence of Renal Cell Carcinoma Presenting as a Haemorrhoid. Journal of Surgical Case Reports, 3... JRL Davies,G Smith,AJ Cornaby,... - 《Journal of Surgical Case Reports》 被引量: 0发表: 2015年 Stapled haemorrhoidectomy (haemorrhoidopexy) for the treatment of ...
Clear cell renal cell carcinoma (ccRCC) is a complex disease with remarkable immune and metabolic heterogeneity. Here we perform genomic, transcriptomic, proteomic, metabolomic and spatial transcriptomic and metabolomic analyses on 100 patients with ccRC
The treatment of renal cell carcinoma (RCC) has changed greatly over the past 15 years. Progress in the surgical management of the primary tumor and increased understanding of the molecular biology and genomics of the disease have led to the development of new therapeutic agents. The management ...
A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statisticall
Few published studies have combined prognostic factors to predict the likelihood of recurrence after surgery for renal cell carcinoma. We developed a nomog... MW Kattan,V Reuter,RJ Motzer,... - 《J Urol》 被引量: 1125发表: 2001年 Cardiac toxicity of sunitinib and sorafenib in patients with...